The Medical Research Network, LLC

New York, New York 10128r

2 studies enrolling now · 54 studies all time

What they study most

Adjunctive Treatment of Major Depressive Disorder, Adult Attention Deficit Hyperactivity Disorder, Alzheimer Disease, Arthritis, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), Binge Eating Disorder, Borderline Personality Disorder, Chronic Low Back Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain

Studies at this site

A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression — Recruiting now
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) — Recruiting now
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Running, not enrolling
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder — Completed
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD — Running, not enrolling
A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder — Completed
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) — Completed
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy — Completed
A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression — Completed
A Study of JNJ-61393215 in the Treatment of Depression — Completed
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression — Completed
Cariprazine Versus Placebo for Social Anxiety Disorder — Completed
A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder — Completed
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Stopped early
Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Completed
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder — Completed
RN624 In Adult Patients With Chronic Low Back Pain — Completed
A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
Tanezumab In Osteoarthritis Of The Knee (2) — Completed
Extension Study Of Tanezumab In Osteoarthritis — Stopped early
Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
Tanezumab in Osteoarthritis of the Knee — Completed
Tanezumab in Osteoarthritis Of The Hip — Completed
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) — Completed
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain — Completed
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD) — Stopped early
Study of Rapastinel as Monotherapy in Patients With MDD — Stopped early
Dasotraline Binge Eating Disorder Extension Study — Completed
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder — Completed
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder — Completed
A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) — Completed
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery — Completed
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder — Completed
A Study of Intermittent Doses of CERC-301 in MDD — Completed
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) — Completed
A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) — Completed
Open-label Safety Study in Adults With ADHD — Completed
12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder — Completed